BAP1 was lost to a lesser extent in CCA-Like (45% of samples) than CCA (80% of samples); however, at a significantly greater frequency than HCC (12%) (p < 0.05) (Supplementary Table 2 and Fig. 5b). This evidence concerns the gene BAP1 and cholangiocarcinoma.